Randomized Trial of Exercise and Nutrition on Chemotherapy Completion and Pathologic Complete Response in Women With Breast Cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis Study.


Journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
ISSN: 1527-7755
Titre abrégé: J Clin Oncol
Pays: United States
ID NLM: 8309333

Informations de publication

Date de publication:
01 Dec 2023
Historique:
medline: 30 11 2023
pubmed: 1 9 2023
entrez: 1 9 2023
Statut: ppublish

Résumé

Successful completion of chemotherapy is critical to improve breast cancer outcomes. Relative dose intensity (RDI), defined as the ratio of chemotherapy delivered to prescribed, is a measure of chemotherapy completion and is associated with cancer mortality. The effect of exercise and eating a healthy diet on RDI is unknown. We conducted a randomized trial of an exercise and nutrition intervention on RDI and pathologic complete response (pCR) in women diagnosed with breast cancer initiating chemotherapy. One hundred seventy-three women with stage I-III breast cancer were randomly assigned to usual care (UC; n = 86) or a home-based exercise and nutrition intervention with counseling sessions delivered by oncology-certified registered dietitians (n = 87). Chemotherapy dose adjustments and delays and pCR were abstracted from electronic medical records. T-tests and chi-square tests were used to examine the effect of the intervention versus UC on RDI and pCR. Participants randomly assigned to intervention had greater improvements in exercise and diet quality compared with UC ( Although a diet and exercise intervention did not affect RDI, the intervention was associated with a higher pCR in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative and triple-negative breast cancer undergoing neoadjuvant chemotherapy.

Identifiants

pubmed: 37656930
doi: 10.1200/JCO.23.00871
pmc: PMC10691793
doi:

Banques de données

ClinicalTrials.gov
['NCT03314688']

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5285-5295

Références

J Clin Oncol. 2001 May 1;19(9):2381-9
pubmed: 11331316
Cancer Epidemiol Biomarkers Prev. 2021 Jun;30(6):1048-1062
pubmed: 33737299
J Natl Cancer Inst. 2012 Jun 6;104(11):815-40
pubmed: 22570317
Br J Sports Med. 2022 Apr;56(7):402-409
pubmed: 35105604
Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1498-508
pubmed: 23780838
Support Care Cancer. 2022 Apr;30(4):3073-3083
pubmed: 34811570
Cancer Epidemiol Biomarkers Prev. 2020 Jun;29(6):1179-1187
pubmed: 32409489
J Clin Oncol. 2016 Mar 1;34(7):669-76
pubmed: 26598750
J Clin Oncol. 2022 Aug 1;40(22):2491-2507
pubmed: 35576506
Ann Epidemiol. 1999 Apr;9(3):178-87
pubmed: 10192650
Med Sci Sports Exerc. 2019 Nov;51(11):2375-2390
pubmed: 31626055
Diabetes Care. 1990 Apr;13(4):401-11
pubmed: 2318100
Breast Cancer Res Treat. 2012 May;133(1):301-10
pubmed: 22270932
Support Care Cancer. 2018 Apr;26(4):1019-1028
pubmed: 29243164
Cell Metab. 2018 Jan 9;27(1):10-21
pubmed: 29056514
JMIR Public Health Surveill. 2023 Mar 8;9:e44105
pubmed: 36884274
J Clin Oncol. 2012 May 20;30(15):1796-804
pubmed: 22508812
J Clin Oncol. 1991 Nov;9(11):2042-51
pubmed: 1941063
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Clin Cancer Res. 2019 Sep 1;25(17):5398-5406
pubmed: 31018921
CA Cancer J Clin. 2022 May;72(3):230-262
pubmed: 35294043
N Engl J Med. 1995 Apr 6;332(14):901-6
pubmed: 7877646
Contemp Clin Trials. 2021 Feb;101:106242
pubmed: 33301991
Breast Cancer. 2021 May;28(3):618-629
pubmed: 33387284
Cancer. 2003 Apr 1;97(7):1746-57
pubmed: 12655532
BMC Cancer. 2019 Jul 25;19(1):737
pubmed: 31345179
Clin Breast Cancer. 2019 Dec;19(6):411-422
pubmed: 31601479
Menopause. 2017 Mar;24(3):322-344
pubmed: 27779567
Contemp Clin Trials. 2021 Oct;109:106508
pubmed: 34274495
J Clin Oncol. 2023 Jan 10;41(2):316-326
pubmed: 36455189
Crit Rev Oncol Hematol. 2019 Apr;136:79-85
pubmed: 30878132
Cancer Res. 2021 Oct 1;81(19):4889-4895
pubmed: 34215623
JAMA Oncol. 2018 Jun 1;4(6):798-804
pubmed: 29621380
J Natl Cancer Inst. 2015 Mar 16;107(5):
pubmed: 25780062
J Clin Oncol. 2007 Oct 1;25(28):4396-404
pubmed: 17785708
Nutrients. 2022 Jul 19;14(14):
pubmed: 35889914
NPJ Breast Cancer. 2016 Aug 24;2:16026
pubmed: 28721384
J Clin Oncol. 2015 Jun 10;33(17):1918-27
pubmed: 25918291
Ann Oncol. 2014 Jul;25(7):1293-1311
pubmed: 24644304
J Clin Oncol. 2020 May 1;38(13):1419-1428
pubmed: 32031879

Auteurs

Tara Sanft (T)

Yale University School of Medicine, New Haven, CT.
Yale Cancer Center, New Haven, CT.

Maura Harrigan (M)

Yale School of Public Health, New Haven, CT.

Courtney McGowan (C)

Yale School of Public Health, New Haven, CT.

Brenda Cartmel (B)

Yale Cancer Center, New Haven, CT.
Yale School of Public Health, New Haven, CT.

Michelle Zupa (M)

Yale School of Public Health, New Haven, CT.

Fang-Yong Li (FY)

Yale School of Public Health, New Haven, CT.

Leah M Ferrucci (LM)

Yale Cancer Center, New Haven, CT.
Yale School of Public Health, New Haven, CT.

Leah Puklin (L)

Yale School of Public Health, New Haven, CT.

Anlan Cao (A)

Yale School of Public Health, New Haven, CT.

Thai Hien Nguyen (TH)

Yale School of Public Health, New Haven, CT.

Marian L Neuhouser (ML)

Fred Hutchinson Cancer Research Center, Seattle, WA.

Dawn L Hershman (DL)

Columbia University Medical Center, New York, NY.

Karen Basen-Engquist (K)

The University of Texas MD Anderson Cancer Center, Houston, TX.

Beth A Jones (BA)

Yale Cancer Center, New Haven, CT.
Yale School of Public Health, New Haven, CT.

Tish Knobf (T)

Yale Cancer Center, New Haven, CT.
Yale School of Nursing, New Haven, CT.

Anees B Chagpar (AB)

Yale University School of Medicine, New Haven, CT.
Yale Cancer Center, New Haven, CT.

Andrea Silber (A)

Yale University School of Medicine, New Haven, CT.
Yale Cancer Center, New Haven, CT.

Anna Tanasijevic (A)

Dana-Farber Cancer Institute, Boston, MA.

Jennifer A Ligibel (JA)

Dana-Farber Cancer Institute, Boston, MA.

Melinda L Irwin (ML)

Yale Cancer Center, New Haven, CT.
Yale School of Public Health, New Haven, CT.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH